Lumonol Review

by Avanse Nutraceuticals
8.00 out of 10 based on 0 user ratings
Written by: Brain Research Supplements
Date Published: 2016-04-08
8.00 / 10 stars
Lumonol  Review

Is Lumonol Right For You?

Lumonol isn’t exactly the most popular brain supplement out there, but we have to say that it’s one of the most interesting pre-made nootropic that we’ve reviewed so far.

Lumonol is a pretty new cognitive supplement. Developed and produced by Avanse Nutraceuticals, this formula promises some amazing results. The problem with these claims is that we can’t confirm or infirm them. Lumonol is so new (the supplement was released in the beginning of this year) that there aren’t many reviews and testimonials online. In fact, excepting the official website, there isn’t much information about Lumonol at all.

But diving into the official website, you’ll immediately notice that you need not look further for more information about the product because the whole site is packed full of everything you might ever need to know about Lumonol. The website contains extensive information on everything from how it works, ingredients, what is supposed to do, clinical studies, manufacturing processes, the science behind the formula, and much more. We have to admit that Lumonol has one of the most comprehensive websites, which is, after all, extremely important purchasing supplements that directly affect processes in your brain.

Ingredients of Lumonol

Lumonol includes the following ingredients: Lumonol includes the following ingredients: Vitamin B12 250 mcg, Memory Blend 285 mg (Citicoline, Ginkgo Biloba, Noopept, and Panax Ginseng), Focus Blend 500 mg (Acetyl L-Carnitine, L-Tyrosine, and Phosphatidylserine), and Energy Blend 375 mg (Guarana, Hordenine, and Picamilon).

Rate this post
shareShare on FacebookShare on Google+Pin on Pinterest
Have a comment or question about Lumonol Review?

(Please Note: Comments or questions which include website links or do not contain positive factual language will not be posted.)

Your email address will not be published.